Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®
October 11, 2017 08:45 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test
September 25, 2017 08:00 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report
September 21, 2017 08:30 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests...
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements
September 20, 2017 09:10 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Appointment of New Director
September 13, 2017 08:30 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test
September 11, 2017 08:00 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City
September 07, 2017 08:30 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
August 31, 2017 08:30 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) will present at the 6th Annual Gateway investor conference, to be held on September 6-7, 2017 at...
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price
August 31, 2017 08:00 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Renewal and Extension of LabCorp National Agreement
August 28, 2017 08:00 ET
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), announced today that the Company has extended its agreement with...